Related Experiment Videos
DNA topoisomerase I inhibitors
C H Takimoto1, L V Kieffer, S G Arbuck
1Navy Medical Oncology Branch, National Cancer Institute, Naval Hospital Bethesda, MD 20889-5105, USA.
Cancer Chemotherapy and Biological Response Modifiers
|January 1, 1997
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Translation of anticancer efficacy from nonclinical models to the clinic.
CPT: pharmacometrics & systems pharmacology·2014
Mechanism-based pharmacokinetic/pharmacodynamic model for troxacitabine-induced neutropenia in cancer patients.
Cancer chemotherapy and pharmacology·2010
N-(phosphonacetyl)-L-aspartate and calcium leucovorin modulation of fluorouracil administered by constant rate and circadian pattern of infusion over 72 hours in metastatic gastrointestinal adenocarcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2002
A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patients.
Cancer chemotherapy and pharmacology·2001
Cardiac function following combination therapy with paclitaxel and doxorubicin: an analysis of 657 women with advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2001
Status of ocular health and binocular vision among children using digital devices: a cross-sectional study.
Annals of medicine and surgery (2012)·2026
Epigenetic regulation of tubular epithelial cell dysfunction in diabetic kidney disease.
International urology and nephrology·2026
AI-Driven Digital Tools for Atopic Dermatitis: A Scoping Review.
Clinical and experimental dermatology·2026
User demographics and real-world use of the digital diabetes companion app dibi: a retrospective analysis.
Frontiers in digital health·2026
Clinical impact of disposable elevator-cap duodenoscopes on post-ERCP cholangitis: a prospective cohort study.
Gastrointestinal endoscopy·2026